Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients
Primary Purpose
Glaucoma
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
randomized to day ward
randomized to inpaitent
Sponsored by
About this trial
This is an interventional health services research trial for Glaucoma focused on measuring knowledge, psychology
Eligibility Criteria
Inclusion Criteria:
- Patient is diagnosed with glaucoma;
- Will receive glaucoma surgery;
- Voluntary participation in this study;
- Have enough language comprehension ability;
- Best corrected visual acuity reach 0.1 or better;
- Patient or his legal representative has sign the informed consent.
Exclusion Criteria:
- Patient with mental disorder;
- There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases;
- Patient with monocular blindness;
- Axial length≤20 mm;
- With other serious eye diseases;
- Neurologic diseases that could affect the visual field;
- 3 months prior to research to participate in any clinical study;
- Researchers think not suitable to participate in this clinical trial subjects;
- Refused to sign the informed consent.
Sites / Locations
- Zhongshan Ophthalmic Center, Sun Yat-San Univerdity
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
day-ward group
inpatient group
Arm Description
Outcomes
Primary Outcome Measures
Change of depression and anxiety score
The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21.
Change of glaucoma knowledge score
The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge.
Secondary Outcome Measures
Full Information
NCT ID
NCT03125850
First Posted
April 16, 2017
Last Updated
July 22, 2020
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
1. Study Identification
Unique Protocol Identification Number
NCT03125850
Brief Title
Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients
Official Title
Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients
Study Type
Interventional
2. Study Status
Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
August 10, 2017 (Actual)
Primary Completion Date
December 10, 2017 (Actual)
Study Completion Date
January 10, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will compare the glaucoma day-ward patients' efficacy with inpatients by evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the differences. Half of participants will receive treatment in day-ward, while the other half will receive treatment in hospital.
Detailed Description
Ophthalmic surgery has short operative time, quick recovery, and small anesthesia risk, making day case surgery the main management mode of ophthalmic surgery. This study will explore the differences of psychology and glaucoma knowledge between glaucoma day-ward patients and the inpatients. The data will be collected by scale on admission and discharge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma
Keywords
knowledge, psychology
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
240 (Actual)
8. Arms, Groups, and Interventions
Arm Title
day-ward group
Arm Type
Experimental
Arm Title
inpatient group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
randomized to day ward
Intervention Description
Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge
Intervention Type
Other
Intervention Name(s)
randomized to inpaitent
Intervention Description
Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge
Primary Outcome Measure Information:
Title
Change of depression and anxiety score
Description
The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21.
Time Frame
at baseline and 1 hour before discharge
Title
Change of glaucoma knowledge score
Description
The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge.
Time Frame
at baseline and 1 hour before discharge
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient is diagnosed with glaucoma;
Will receive glaucoma surgery;
Voluntary participation in this study;
Have enough language comprehension ability;
Best corrected visual acuity reach 0.1 or better;
Patient or his legal representative has sign the informed consent.
Exclusion Criteria:
Patient with mental disorder;
There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases;
Patient with monocular blindness;
Axial length≤20 mm;
With other serious eye diseases;
Neurologic diseases that could affect the visual field;
3 months prior to research to participate in any clinical study;
Researchers think not suitable to participate in this clinical trial subjects;
Refused to sign the informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mingkai Lin, MD
Organizational Affiliation
Zhongshan Ophthalmic Center, Sun Yat-San University
Official's Role
Study Chair
Facility Information:
Facility Name
Zhongshan Ophthalmic Center, Sun Yat-San Univerdity
City
Guangzhou
State/Province
Guangdong
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No.
Learn more about this trial
Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients
We'll reach out to this number within 24 hrs